Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
CAL-120 | Cediranib | VEGFR/cKIT | RTK | 1.037 | -0.1243 | 0.2989 | 0.0564 | 0.5757 | 6.9922 | 0.99099 |
MDA-MB-361 | Cediranib | VEGFR/cKIT | RTK | 2.2171 | -0.9803 | 0.2895 | 0.1040 | 2.2939 | 3.5791 | 0.96048 |
HCC1500 | Cediranib | VEGFR/cKIT | RTK | 3.8594 | -0.8084 | 0.1304 | 0.0735 | 3.4916 | 5.2864 | 0.99235 |
HCC1937 | Cediranib | VEGFR/cKIT | RTK | 7.9267 | 0.2784 | 0.0440 | 0.0316 | 3.5480 | 8.352 | 0.99376 |
MDA-MB-134-VI | Cediranib | VEGFR/cKIT | RTK | 4.2103 | -0.9999 | 0.0977 | 0.0979 | 5.0000 | 5.2449 | 0.99321 |
CAL-51 | Cediranib | VEGFR/cKIT | RTK | 3.0488 | -0.1033 | 0.1710 | 0.0517 | 1.0331 | 8.8303 | 0.9776 |
SUM159PT | Cediranib | VEGFR/cKIT | RTK | 8.1187 | 0.3173 | 0.0491 | 0.0085 | 2.1882 | 12.8042 | 0.99762 |
MDA-MB-453 | Cediranib | VEGFR/cKIT | RTK | 2.7824 | -0.6894 | 0.1569 | 0.0768 | 3.0858 | 3.7659 | 0.99464 |
MDA-MB-436 | Cediranib | VEGFR/cKIT | RTK | 3.6098 | -0.3824 | 0.1610 | 0.0446 | 1.8229 | 6.595 | 0.98039 |
CAL-85-1 | Cediranib | VEGFR/cKIT | RTK | 2.4003 | -0.2379 | 0.1869 | 0.0514 | 1.1002 | 6.5151 | 0.99569 |
T47D | Cediranib | VEGFR/cKIT | RTK | 4.1027 | -0.6403 | 0.1246 | 0.0754 | 2.9281 | 5.9706 | 0.99504 |
PDX1258 | Cediranib | VEGFR/cKIT | RTK | 4.7159 | -0.5611 | 0.0744 | 0.0681 | 4.9799 | 5.5703 | 0.99375 |
MCF7 | Cediranib | VEGFR/cKIT | RTK | 5.7041 | 0.1149 | 0.0758 | 0.0191 | 1.5383 | 11.6508 | 0.98993 |
HCC1419 | Cediranib | VEGFR/cKIT | RTK | 5.0599 | -0.0329 | 0.0545 | 0.0124 | 4.9952 | 5.1984 | 0.99032 |
SUM1315MO2 | Cediranib | VEGFR/cKIT | RTK | 1.4839 | -0.2276 | 0.2430 | 0.0500 | 0.7936 | 5.924 | 0.99038 |